Loading clinical trials...
Loading clinical trials...
This trial is conducted in Europe, Asia, Oceania and the United States of America (USA). This is a one-year clinical trial to compare the safety of inhaled preprandial human insulin to subcutaneous i...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novo Nordisk A/S
NCT07187830 · Chronic Kidney Disease in Type 2 Diabetes, Obesity & Overweight
NCT06310356 · Gestational Diabetes
NCT06613854 · Type 2 Diabetes Mellitus (T2DM)
NCT05398783 · Metabolic Disorders, Cancer, and more
NCT07535307 · Diabetes Mellitus
Novo Nordisk Investigational Site
Fresno, California
Novo Nordisk Investigational Site
New Orleans, Louisiana
Novo Nordisk Investigational Site
Kansas City, Missouri
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions